Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169- Inflation Reduction Act of 2022. Support for EPIC Act - H.R. 1492
Literal federal measure citations: H.R. 1492
2025 · 1st Quarter (Jan 1 - Mar 31)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Filed by THE MCMANUS GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- THE MCMANUS GROUP
- Filing UUID
- 9150a251-7b32-4d20-b9e9-730346e0a6c5
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.